aluates Reports

$ 0.0

Automative

Global Multi Cancer Early Detection Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-1Z13485

Global Multi Cancer Early Detection Market Research Report 2023

BUY CHAPTERS

Global Multi Cancer Early Detection Market Research Report 2025

Code: QYRE-Auto-1Z13485

Report

March 2025

Pages:78

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Exact Sciences Corporation

Foundation Medicine, Inc

AnchorDx

GUARDANT HEALTH, INC

Laboratory For Advanced Medicine Inc

Grail, LLC (Illumina, Inc.)

Burning Rock Biotech Limited

GENECAST

Singlera Genomics Inc.

Multi Cancer Early Detection Market

The global market for Multi Cancer Early Detection was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Multi-cancer early detection (MCED) tests are tests that measure biological signals in body fluids that may be shed by cancer cells. These signals are also known as biomarkers or tumor markers. MCED tests are being developed to screen for cancers from more than one organ site at the same time.

North American market for Multi Cancer Early Detection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Multi Cancer Early Detection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Multi Cancer Early Detection in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Multi Cancer Early Detection include Grail, LLC (Illumina, Inc.), Exact Sciences Corporation., Foundation Medicine, Inc., AnchorDx, Guardant Health, Inc., Burning Rock Biotech Limited, GENECAST, Laboratory for Advanced Medicine, Inc., Singlera Genomics Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Multi Cancer Early Detection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Multi Cancer Early Detection.

The Multi Cancer Early Detection market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Multi Cancer Early Detection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Multi Cancer Early Detection companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Multi Cancer Early Detection Market Report

Report Metric	Details
Report Name	Multi Cancer Early Detection Market
Segment by Type	Liquid Biopsy Gene Panel, LDT & Others
Segment by Application	Hospitals Diagnostic Laboratories Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Grail, LLC (Illumina, Inc.), Exact Sciences Corporation., Foundation Medicine, Inc., AnchorDx, Guardant Health, Inc., Burning Rock Biotech Limited, GENECAST, Laboratory for Advanced Medicine, Inc., Singlera Genomics Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Multi Cancer Early Detection company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Multi Cancer Early Detection Market report?

Ans: The main players in the Multi Cancer Early Detection Market are Grail, LLC (Illumina, Inc.), Exact Sciences Corporation., Foundation Medicine, Inc., AnchorDx, Guardant Health, Inc., Burning Rock Biotech Limited, GENECAST, Laboratory for Advanced Medicine, Inc., Singlera Genomics Inc.

What are the Application segmentation covered in the Multi Cancer Early Detection Market report?

Ans: The Applications covered in the Multi Cancer Early Detection Market report are Hospitals, Diagnostic Laboratories, Others

What are the Type segmentation covered in the Multi Cancer Early Detection Market report?

Ans: The Types covered in the Multi Cancer Early Detection Market report are Liquid Biopsy, Gene Panel, LDT & Others

Recommended Reports

Cancer Detection

Genomics & Markers

Multi-Cancer Diagnostics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Multi Cancer Early Detection Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Liquid Biopsy

1.2.3 Gene Panel, LDT & Others

1.3 Market by Application

1.3.1 Global Multi Cancer Early Detection Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Diagnostic Laboratories

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Multi Cancer Early Detection Market Perspective (2020-2031)

2.2 Global Multi Cancer Early Detection Growth Trends by Region

2.2.1 Global Multi Cancer Early Detection Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Multi Cancer Early Detection Historic Market Size by Region (2020-2025)

2.2.3 Multi Cancer Early Detection Forecasted Market Size by Region (2026-2031)

2.3 Multi Cancer Early Detection Market Dynamics

2.3.1 Multi Cancer Early Detection Industry Trends

2.3.2 Multi Cancer Early Detection Market Drivers

2.3.3 Multi Cancer Early Detection Market Challenges

2.3.4 Multi Cancer Early Detection Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Multi Cancer Early Detection Players by Revenue

3.1.1 Global Top Multi Cancer Early Detection Players by Revenue (2020-2025)

3.1.2 Global Multi Cancer Early Detection Revenue Market Share by Players (2020-2025)

3.2 Global Multi Cancer Early Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Multi Cancer Early Detection Revenue

3.4 Global Multi Cancer Early Detection Market Concentration Ratio

3.4.1 Global Multi Cancer Early Detection Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Multi Cancer Early Detection Revenue in 2024

3.5 Global Key Players of Multi Cancer Early Detection Head office and Area Served

3.6 Global Key Players of Multi Cancer Early Detection, Product and Application

3.7 Global Key Players of Multi Cancer Early Detection, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Multi Cancer Early Detection Breakdown Data by Type

4.1 Global Multi Cancer Early Detection Historic Market Size by Type (2020-2025)

4.2 Global Multi Cancer Early Detection Forecasted Market Size by Type (2026-2031)

5 Multi Cancer Early Detection Breakdown Data by Application

5.1 Global Multi Cancer Early Detection Historic Market Size by Application (2020-2025)

5.2 Global Multi Cancer Early Detection Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Multi Cancer Early Detection Market Size (2020-2031)

6.2 North America Multi Cancer Early Detection Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Multi Cancer Early Detection Market Size by Country (2020-2025)

6.4 North America Multi Cancer Early Detection Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Multi Cancer Early Detection Market Size (2020-2031)

7.2 Europe Multi Cancer Early Detection Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Multi Cancer Early Detection Market Size by Country (2020-2025)

7.4 Europe Multi Cancer Early Detection Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Multi Cancer Early Detection Market Size (2020-2031)

8.2 Asia-Pacific Multi Cancer Early Detection Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Multi Cancer Early Detection Market Size by Region (2020-2025)

8.4 Asia-Pacific Multi Cancer Early Detection Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Multi Cancer Early Detection Market Size (2020-2031)

9.2 Latin America Multi Cancer Early Detection Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Multi Cancer Early Detection Market Size by Country (2020-2025)

9.4 Latin America Multi Cancer Early Detection Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Multi Cancer Early Detection Market Size (2020-2031)

10.2 Middle East & Africa Multi Cancer Early Detection Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Multi Cancer Early Detection Market Size by Country (2020-2025)

10.4 Middle East & Africa Multi Cancer Early Detection Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Grail, LLC (Illumina, Inc.)

11.1.1 Grail, LLC (Illumina, Inc.) Company Details

11.1.2 Grail, LLC (Illumina, Inc.) Business Overview

11.1.3 Grail, LLC (Illumina, Inc.) Multi Cancer Early Detection Introduction

11.1.4 Grail, LLC (Illumina, Inc.) Revenue in Multi Cancer Early Detection Business (2020-2025)

11.1.5 Grail, LLC (Illumina, Inc.) Recent Development

11.2 Exact Sciences Corporation.

11.2.1 Exact Sciences Corporation. Company Details

11.2.2 Exact Sciences Corporation. Business Overview

11.2.3 Exact Sciences Corporation. Multi Cancer Early Detection Introduction

11.2.4 Exact Sciences Corporation. Revenue in Multi Cancer Early Detection Business (2020-2025)

11.2.5 Exact Sciences Corporation. Recent Development

11.3 Foundation Medicine, Inc.

11.3.1 Foundation Medicine, Inc. Company Details

11.3.2 Foundation Medicine, Inc. Business Overview

11.3.3 Foundation Medicine, Inc. Multi Cancer Early Detection Introduction

11.3.4 Foundation Medicine, Inc. Revenue in Multi Cancer Early Detection Business (2020-2025)

11.3.5 Foundation Medicine, Inc. Recent Development

11.4 AnchorDx

11.4.1 AnchorDx Company Details

11.4.2 AnchorDx Business Overview

11.4.3 AnchorDx Multi Cancer Early Detection Introduction

11.4.4 AnchorDx Revenue in Multi Cancer Early Detection Business (2020-2025)

11.4.5 AnchorDx Recent Development

11.5 Guardant Health, Inc.

11.5.1 Guardant Health, Inc. Company Details

11.5.2 Guardant Health, Inc. Business Overview

11.5.3 Guardant Health, Inc. Multi Cancer Early Detection Introduction

11.5.4 Guardant Health, Inc. Revenue in Multi Cancer Early Detection Business (2020-2025)

11.5.5 Guardant Health, Inc. Recent Development

11.6 Burning Rock Biotech Limited

11.6.1 Burning Rock Biotech Limited Company Details

11.6.2 Burning Rock Biotech Limited Business Overview

11.6.3 Burning Rock Biotech Limited Multi Cancer Early Detection Introduction

11.6.4 Burning Rock Biotech Limited Revenue in Multi Cancer Early Detection Business (2020-2025)

11.6.5 Burning Rock Biotech Limited Recent Development

11.7 GENECAST

11.7.1 GENECAST Company Details

11.7.2 GENECAST Business Overview

11.7.3 GENECAST Multi Cancer Early Detection Introduction

11.7.4 GENECAST Revenue in Multi Cancer Early Detection Business (2020-2025)

11.7.5 GENECAST Recent Development

11.8 Laboratory for Advanced Medicine, Inc.

11.8.1 Laboratory for Advanced Medicine, Inc. Company Details

11.8.2 Laboratory for Advanced Medicine, Inc. Business Overview

11.8.3 Laboratory for Advanced Medicine, Inc. Multi Cancer Early Detection Introduction

11.8.4 Laboratory for Advanced Medicine, Inc. Revenue in Multi Cancer Early Detection Business (2020-2025)

11.8.5 Laboratory for Advanced Medicine, Inc. Recent Development

11.9 Singlera Genomics Inc.

11.9.1 Singlera Genomics Inc. Company Details

11.9.2 Singlera Genomics Inc. Business Overview

11.9.3 Singlera Genomics Inc. Multi Cancer Early Detection Introduction

11.9.4 Singlera Genomics Inc. Revenue in Multi Cancer Early Detection Business (2020-2025)

11.9.5 Singlera Genomics Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Exact Sciences Corporation

Foundation Medicine, Inc

AnchorDx

GUARDANT HEALTH, INC

Laboratory For Advanced Medicine Inc

Grail, LLC (Illumina, Inc.)

Burning Rock Biotech Limited

GENECAST

Singlera Genomics Inc.

List of Tables

Table 1. Global Multi Cancer Early Detection Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Liquid Biopsy

Table 3. Key Players of Gene Panel, LDT & Others

Table 4. Global Multi Cancer Early Detection Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Multi Cancer Early Detection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Multi Cancer Early Detection Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Multi Cancer Early Detection Market Share by Region (2020-2025)

Table 8. Global Multi Cancer Early Detection Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Multi Cancer Early Detection Market Share by Region (2026-2031)

Table 10. Multi Cancer Early Detection Market Trends

Table 11. Multi Cancer Early Detection Market Drivers

Table 12. Multi Cancer Early Detection Market Challenges

Table 13. Multi Cancer Early Detection Market Restraints

Table 14. Global Multi Cancer Early Detection Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Multi Cancer Early Detection Market Share by Players (2020-2025)

Table 16. Global Top Multi Cancer Early Detection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multi Cancer Early Detection as of 2024)

Table 17. Ranking of Global Top Multi Cancer Early Detection Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Multi Cancer Early Detection Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Multi Cancer Early Detection, Headquarters and Area Served

Table 20. Global Key Players of Multi Cancer Early Detection, Product and Application

Table 21. Global Key Players of Multi Cancer Early Detection, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Multi Cancer Early Detection Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Multi Cancer Early Detection Revenue Market Share by Type (2020-2025)

Table 25. Global Multi Cancer Early Detection Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Multi Cancer Early Detection Revenue Market Share by Type (2026-2031)

Table 27. Global Multi Cancer Early Detection Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Multi Cancer Early Detection Revenue Market Share by Application (2020-2025)

Table 29. Global Multi Cancer Early Detection Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Multi Cancer Early Detection Revenue Market Share by Application (2026-2031)

Table 31. North America Multi Cancer Early Detection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Multi Cancer Early Detection Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Multi Cancer Early Detection Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Multi Cancer Early Detection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Multi Cancer Early Detection Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Multi Cancer Early Detection Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Multi Cancer Early Detection Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Multi Cancer Early Detection Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Multi Cancer Early Detection Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Multi Cancer Early Detection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Multi Cancer Early Detection Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Multi Cancer Early Detection Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Multi Cancer Early Detection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Multi Cancer Early Detection Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Multi Cancer Early Detection Market Size by Country (2026-2031) & (US$ Million)

Table 46. Grail, LLC (Illumina, Inc.) Company Details

Table 47. Grail, LLC (Illumina, Inc.) Business Overview

Table 48. Grail, LLC (Illumina, Inc.) Multi Cancer Early Detection Product

Table 49. Grail, LLC (Illumina, Inc.) Revenue in Multi Cancer Early Detection Business (2020-2025) & (US$ Million)

Table 50. Grail, LLC (Illumina, Inc.) Recent Development

Table 51. Exact Sciences Corporation. Company Details

Table 52. Exact Sciences Corporation. Business Overview

Table 53. Exact Sciences Corporation. Multi Cancer Early Detection Product

Table 54. Exact Sciences Corporation. Revenue in Multi Cancer Early Detection Business (2020-2025) & (US$ Million)

Table 55. Exact Sciences Corporation. Recent Development

Table 56. Foundation Medicine, Inc. Company Details

Table 57. Foundation Medicine, Inc. Business Overview

Table 58. Foundation Medicine, Inc. Multi Cancer Early Detection Product

Table 59. Foundation Medicine, Inc. Revenue in Multi Cancer Early Detection Business (2020-2025) & (US$ Million)

Table 60. Foundation Medicine, Inc. Recent Development

Table 61. AnchorDx Company Details

Table 62. AnchorDx Business Overview

Table 63. AnchorDx Multi Cancer Early Detection Product

Table 64. AnchorDx Revenue in Multi Cancer Early Detection Business (2020-2025) & (US$ Million)

Table 65. AnchorDx Recent Development

Table 66. Guardant Health, Inc. Company Details

Table 67. Guardant Health, Inc. Business Overview

Table 68. Guardant Health, Inc. Multi Cancer Early Detection Product

Table 69. Guardant Health, Inc. Revenue in Multi Cancer Early Detection Business (2020-2025) & (US$ Million)

Table 70. Guardant Health, Inc. Recent Development

Table 71. Burning Rock Biotech Limited Company Details

Table 72. Burning Rock Biotech Limited Business Overview

Table 73. Burning Rock Biotech Limited Multi Cancer Early Detection Product

Table 74. Burning Rock Biotech Limited Revenue in Multi Cancer Early Detection Business (2020-2025) & (US$ Million)

Table 75. Burning Rock Biotech Limited Recent Development

Table 76. GENECAST Company Details

Table 77. GENECAST Business Overview

Table 78. GENECAST Multi Cancer Early Detection Product

Table 79. GENECAST Revenue in Multi Cancer Early Detection Business (2020-2025) & (US$ Million)

Table 80. GENECAST Recent Development

Table 81. Laboratory for Advanced Medicine, Inc. Company Details

Table 82. Laboratory for Advanced Medicine, Inc. Business Overview

Table 83. Laboratory for Advanced Medicine, Inc. Multi Cancer Early Detection Product

Table 84. Laboratory for Advanced Medicine, Inc. Revenue in Multi Cancer Early Detection Business (2020-2025) & (US$ Million)

Table 85. Laboratory for Advanced Medicine, Inc. Recent Development

Table 86. Singlera Genomics Inc. Company Details

Table 87. Singlera Genomics Inc. Business Overview

Table 88. Singlera Genomics Inc. Multi Cancer Early Detection Product

Table 89. Singlera Genomics Inc. Revenue in Multi Cancer Early Detection Business (2020-2025) & (US$ Million)

Table 90. Singlera Genomics Inc. Recent Development

Table 91. Research Programs/Design for This Report

Table 92. Key Data Information from Secondary Sources

Table 93. Key Data Information from Primary Sources

Table 94. Authors List of This Report

List of Figures

Figure 1. Multi Cancer Early Detection Picture

Figure 2. Global Multi Cancer Early Detection Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Multi Cancer Early Detection Market Share by Type: 2024 VS 2031

Figure 4. Liquid Biopsy Features

Figure 5. Gene Panel, LDT & Others Features

Figure 6. Global Multi Cancer Early Detection Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Multi Cancer Early Detection Market Share by Application: 2024 VS 2031

Figure 8. Hospitals Case Studies

Figure 9. Diagnostic Laboratories Case Studies

Figure 10. Others Case Studies

Figure 11. Multi Cancer Early Detection Report Years Considered

Figure 12. Global Multi Cancer Early Detection Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Multi Cancer Early Detection Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Multi Cancer Early Detection Market Share by Region: 2024 VS 2031

Figure 15. Global Multi Cancer Early Detection Market Share by Players in 2024

Figure 16. Global Top Multi Cancer Early Detection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multi Cancer Early Detection as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Multi Cancer Early Detection Revenue in 2024

Figure 18. North America Multi Cancer Early Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Multi Cancer Early Detection Market Share by Country (2020-2031)

Figure 20. United States Multi Cancer Early Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Multi Cancer Early Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Multi Cancer Early Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Multi Cancer Early Detection Market Share by Country (2020-2031)

Figure 24. Germany Multi Cancer Early Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Multi Cancer Early Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Multi Cancer Early Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Multi Cancer Early Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Multi Cancer Early Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Multi Cancer Early Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Multi Cancer Early Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Multi Cancer Early Detection Market Share by Region (2020-2031)

Figure 32. China Multi Cancer Early Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Multi Cancer Early Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Multi Cancer Early Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Multi Cancer Early Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Multi Cancer Early Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Multi Cancer Early Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Multi Cancer Early Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Multi Cancer Early Detection Market Share by Country (2020-2031)

Figure 40. Mexico Multi Cancer Early Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Multi Cancer Early Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Multi Cancer Early Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Multi Cancer Early Detection Market Share by Country (2020-2031)

Figure 44. Turkey Multi Cancer Early Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Multi Cancer Early Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Multi Cancer Early Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Grail, LLC (Illumina, Inc.) Revenue Growth Rate in Multi Cancer Early Detection Business (2020-2025)

Figure 48. Exact Sciences Corporation. Revenue Growth Rate in Multi Cancer Early Detection Business (2020-2025)

Figure 49. Foundation Medicine, Inc. Revenue Growth Rate in Multi Cancer Early Detection Business (2020-2025)

Figure 50. AnchorDx Revenue Growth Rate in Multi Cancer Early Detection Business (2020-2025)

Figure 51. Guardant Health, Inc. Revenue Growth Rate in Multi Cancer Early Detection Business (2020-2025)

Figure 52. Burning Rock Biotech Limited Revenue Growth Rate in Multi Cancer Early Detection Business (2020-2025)

Figure 53. GENECAST Revenue Growth Rate in Multi Cancer Early Detection Business (2020-2025)

Figure 54. Laboratory for Advanced Medicine, Inc. Revenue Growth Rate in Multi Cancer Early Detection Business (2020-2025)

Figure 55. Singlera Genomics Inc. Revenue Growth Rate in Multi Cancer Early Detection Business (2020-2025)

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

Figure 58. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Solid Tumor Detection Market Research Report 2024

Global Cancer Imaging System Market Research Report 2025

Global Non invasive Tumor Detection Market Research Report 2024

Global Cancer Cell Media Market Research Report 2024

Global Cancer Insurance Market Research Report 2024

Global Tumor Markers Detection Kit Market Research Report 2025

Global Mammography Screening Market Research Report 2024

Next Generation Cancer Diagnostics Market

Global Cancer Microbiome Market Research Report 2024

Global Cervical Cancer Screening Service Market Research Report 2024

Global Multi Cancer Screening Market Research Report 2024

Global Cancer Screening Technology Market Research Report 2024

Global Early Detection of Multiple Cancers Market Research Report 2024

Global Point of care Cancer Screening Market Research Report 2025

Global Circulating Tumor Cell Detector Market Research Report 2024

Global Rapid Tumor Marker Tests Market Research Report 2025

Global Portable Cancer Screening Devices Market Research Report 2024

Global Precancer Molecular Diagnostics Market Research Report 2024

Cancer Early Detection and Screening Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28I6901

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22R9736

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29A2598

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions